Healionics lands $3.8M for artificial blood vessel to improve dialysis delivery by James Thorne on February 28, 2019March 1, 2019 at 7:21 am Seattle-based medical technology company Healionics raised $3.8 million to support the development of an artificial blood vessel called STARgraft for patients who undergo dialysis treatment. Patients with failed kidneys can undergo… Read More